Potential Involvement of LncRNAs in Cardiometabolic Diseases

被引:4
|
作者
Ilieva, Mirolyuba [1 ]
Uchida, Shizuka [1 ]
机构
[1] Aalborg Univ, Ctr RNA Med, Dept Clin Med, DK-2450 Copenhagen SV, Denmark
关键词
cardiovascular; genetics; lncRNA; metabolism; LONG NONCODING RNA; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; PULMONARY-HYPERTENSION; NEGATIVE REGULATOR; WESTERN DIET; RISK-FACTORS; OBESITY;
D O I
10.3390/genes14010213
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Characterized by cardiovascular disease and diabetes, cardiometabolic diseases are a major cause of mortality around the world. As such, there is an urgent need to understand the pathogenesis of cardiometabolic diseases. Increasing evidence suggests that most of the mammalian genome are transcribed as RNA, but only a few percent of them encode for proteins. All of the RNAs that do not encode for proteins are collectively called non-protein-coding RNAs (ncRNAs). Among these ncRNAs, long ncRNAs (lncRNAs) are considered as missing keys to understand the pathogeneses of various diseases, including cardiometabolic diseases. Given the increased interest in lncRNAs, in this study, we will summarize the latest trend in the lncRNA research from the perspective of cardiometabolism and disease by focusing on the major risk factors of cardiometabolic diseases: obesity, cholesterol, diabetes, and hypertension. Because genetic inheritance is unavoidable in cardiometabolic diseases, we paid special attention to the genetic factors of lncRNAs that may influence cardiometabolic diseases.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Uric acid and cardiometabolic diseases
    Seung Jae Lee
    Byeong Kil Oh
    Ki-Chul Sung
    Clinical Hypertension, 26
  • [32] Therapy of depression in cardiometabolic diseases
    Suehs, K. W.
    Reuther, M.
    NERVENHEILKUNDE, 2012, 31 (05) : 311 - +
  • [33] Cardiometabolic diseases, everyone is concerned
    Rambaud, Aude
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (03): : 439 - 443
  • [34] The evolving landscape of cardiometabolic diseases
    Eroglu, Tolga
    Capone, Federico
    Schiattarella, Gabriele G.
    EBIOMEDICINE, 2024, 109
  • [35] Role of calprotectin in cardiometabolic diseases
    Kruzliak, Peter
    Novak, Jan
    Novak, Miroslav
    Fodor, George J.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (01) : 67 - 75
  • [36] Dietary Fibers and Cardiometabolic Diseases
    Riccioni, Graziano
    Sblendorio, Valeriana
    Gemello, Eugenio
    Di Bello, Barbara
    Scotti, Luca
    Cusenza, Salvatore
    D'Orazio, Nicolantonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (02): : 1524 - 1540
  • [37] Inflammatory markers and cardiometabolic diseases
    Esser, N.
    Paquot, N.
    Scheen, A. J.
    ACTA CLINICA BELGICA, 2015, 70 (03) : 193 - 199
  • [38] Testosterone in cardiometabolic and other diseases
    Carson, Culley
    TRENDS IN UROLOGY & MENS HEALTH, 2022, 13 (05) : 30 - 31
  • [39] Uric acid and cardiometabolic diseases
    Lee, Seung Jae
    Oh, Byeong Kil
    Sung, Ki-Chul
    CLINICAL HYPERTENSION, 2020, 26 (01)
  • [40] Obesity and the risk of cardiometabolic diseases
    Pedro L. Valenzuela
    Pedro Carrera-Bastos
    Adrián Castillo-García
    Daniel E. Lieberman
    Alejandro Santos-Lozano
    Alejandro Lucia
    Nature Reviews Cardiology, 2023, 20 : 475 - 494